Biosimilars
Video
Biosimilar Approval and Adoption Challenges
Accelerating the progress of biosimilars is key to lowering drug costs and improving patient access to potentially life-saving therapies.
Read More
Article
Three specialty drug trends to prepare for: Biosimilars, gene and cell therapies, cancer drugs
Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...
Read More
Article
Game changer: Three things to know about interchangeable biosimilars
The first interchangeable biosimilar is now available. Here’s what plans need to know about these products, which – like generics – can be substituted at the pharmacy.
Read More